The future of hearing loss

Episode Summary

Executive Summary: This episode explores hearing loss as a major global disability and the state of research aimed at better diagnosis, prevention, and treatment. Tina Stankovic explains the biology of hearing, the limits of current devices, and how AI, stem cells, imaging, gene therapy, and regenerative biology are opening new paths to precision diagnosis and future cures.

Main Topics: The global burden and current limits of hearing loss care: Hearing loss affects a vast population and remains largely managed with devices rather than cures. Current care relies mainly on hearing aids and cochlear implants, with limited approved drugs. How hearing works and the difference between conductive and sensorineural loss: The conversation breaks down the ear’s mechanics, from eardrum and ossicles to hair cells and the auditory nerve, and distinguishes conductive problems from inner-ear sensorineural damage. AI for genetic diagnosis and variant interpretation: AI is used to analyze genetic and clinical data to resolve variants of unknown significance, improving diagnostic precision for patients whose genetic testing was previously inconclusive. Stem cells, organoids, and regeneration research: Induced pluripotent stem cells are being turned into inner-ear cells and organoids to model disease and potentially support personalized therapies, while regenerative pathways are being studied in animals and human tissue. Advanced technologies for imaging, surgery, and gene therapy: High-resolution imaging, robotic cochlear implant insertion, and emerging gene therapy are expanding what researchers and surgeons can do in this tiny, inaccessible organ. The lived impact of hearing loss and stigma: Hearing loss can drive isolation, depression, cognitive decline, and social stigma, especially when acquired later in life. Multidisciplinary support is important for affected patients. Prevention and practical hearing protection: Listeners are advised to limit noise exposure, use ear protection, monitor decibel levels, maintain healthy lifestyles, manage chronic disease, and be cautious with certain medications.

Key Arguments: Hearing loss is common, disabling, and still lacks a true cure, so prevention and early diagnosis are critical. Conductive hearing loss is often treatable or surgically correctable, but sensorineural hearing loss remains much harder to diagnose and repair because the inner ear cannot be easily imaged or biopsied. AI can convert ambiguous genetic findings into actionable diagnoses by identifying which variants of unknown significance are likely pathogenic. Stem-cell-derived inner-ear models and organoids make it possible to study disease mechanisms and may eventually support personalized therapies. Regeneration is not spontaneous in the mammalian inner ear, but studying birds and reptiles has revealed pathways that can be activated in mice and possibly in humans. The ear’s unique anatomy and physiology—tiny size, specialized fluids, and dense bone—make it difficult to study, but also drive innovation. Hearing loss affects quality of life beyond sound perception, contributing to isolation, stigma, depression, and possibly cognitive decline. Prevention matters because the most common causes of damage, especially noise exposure and some medications, are modifiable. Multidisciplinary collaboration and public advocacy are essential because hearing research is underfunded relative to its burden.

Data Points: People affected globally: 1.5 billion - Stankovich describes hearing loss as affecting one and a half billion people worldwide. Share of world population: 1 in 6 individuals - Equivalent framing of the global burden of hearing loss. Genetic contribution to hearing loss: About 50% - She states that roughly half of hearing loss is caused by genetic mutations. Diagnostic yield of genetic testing: About 50% precise diagnosis - Genetic testing provides a clear diagnosis in about half of tested patients. Genetic test ambiguity: Hundreds of variants of unknown significance - The remaining cases often contain many unclear genetic findings. Tinnitus improvement after cochlear implantation: 75% improved - Cochlear implantation improves tinnitus in most patients with that symptom. Tinnitus complete resolution after cochlear implantation: 10% - A minority experience full disappearance of tinnitus after implantation. Normal speech loudness: Around 65 decibel - Used as a reference point for everyday conversation volume. Common safe exposure threshold: 85 decibel - Recommended upper limit for sound exposure before risk rises. Many music concerts: Around 120 decibel - Example of potentially damaging noise exposure. Highest recorded football stadium noise: 143 decibel - Cited as louder than a jet engine and capable of causing injury. Magnesium trial result: Less hearing loss with magnesium - A study in Israeli military trainees found protective effects from magnesium supplementation. Biological battery in the inner ear: 100 millivolts positive potential - Describes the endolymph-driven electrical gradient that powers sensory transduction. Inner ear fluid volume: About 140 microliters - The total fluid volume is compared to roughly three raindrops. Current drug prevention example: Cisplatin-induced ototoxicity - The only recently approved drug discussed is for hearing protection from this specific cancer-drug side effect.

Pivotal Quotes: "deafness is a worse misfortune because blindness separates us from things and deafness separates us from people." — Helen Keller (quoted by Tina Stankovich): Used to describe the social and relational isolation caused by hearing loss. "Now, with the use of AI, we can actually determine which of these variants of unknown significance are actually significant." — Tina Stankovich: Explaining how AI improves genetic diagnosis in hearing loss. "If this bone starts to remodel, then it leads to disease, including hearing loss." — Tina Stankovich: Discussing the unusual biology of the otic capsule and why ear anatomy is so specialized.

Implications: The episode suggests hearing care is entering a precision-medicine era: AI may clarify diagnoses, stem-cell and regeneration work may enable future therapies, and prevention remains essential now. For patients, earlier intervention and multidisciplinary support can reduce isolation and long-term harm.